Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity ...

The new weight loss drug offers promising results for those who are overweight or obese. Learn about how Zepbound works, its ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

A randomized, placebo-controlled trial validates a side effect frequently observed by doctors and patients. A new study from ...

Weight loss injections have become incredibly popular in the last year or so. In fact, these medications are so widely used ...

Researchers said the study backs up anecdotal evidence from patients and doctors that semaglutide can lead to a sudden loss of longing for alcoholic drinks ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

At the least, the new 7.2mg results point to scope for hiking the semaglutide dose in CagriSema to chase down that weight-loss target. The company is also running a phase 3b trial of 7.2mg ...

For years, conventional wisdom has been that weight loss is a matter of willpower. Those who are overweight or obese just need to try harder to eat less and exercise more. But while diet and ...

Semaglutide, known as Ozempic, may reduce alcohol cravings and consumption, offering new addiction treatment possibilities.

Another difference between the two is the dosage, she notes ... Four years after starting semaglutide, patients maintained an average weight loss of 10% of their body weight, a peer-reviewed ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...